The client is a leading Life Sciences company specializing in the manufacturing and distribution of pharmaceutical products, committed to improving the health and well-being of patients worldwide.

With a strong focus on innovation and regulatory compliance, the company continuously strives to deliver high-quality and safe drugs to the market. The Life Sciences industry has many regulatory responsibilities, including the obligation to document and maintain consumer feedback on the safety and efficacy of its products.

One of the major life sciences companies in the United States faced the challenge of processing a large volume of adverse event (AE) cases while maintaining their cost base and ensuring accuracy. On average, the company processed 200,000 AE cases annually and with pressure to be more efficient, the company needed to find a solution.

AiRo helped the client company streamline the AE case processing and reduce the requirement for training and manual labor. The solution provided real-time reporting, reduced compliance risk, and eliminated any human error, resulting in improved efficiency and accuracy.

Overcoming accuracy issues and training challenges

Due to a lack of experienced staff, the company was facing accuracy issues and delays in the case intake cycle. This problem generated frequent and rigorous pharmacovigilance (PV) training requirements for the sales staff, which was time-consuming and costly. The company needed a solution that would streamline the AE case processing and reduce the requirement for training and manual labor.

Voice-enabled Chatbot deployment transforms Adverse Event Processing for the client 

AiRo offered a solution to streamline the AE case processing. AiRo piloted a voice-enabled chatbot for PV case intake that was capable of capturing AE data from conversations with patients, reporters, consumers, and healthcare professionals. The chatbot was deployed on the company’s website and mobile platform and was able to capture information from the chat text and populate the adverse drug reaction form fields automatically.

The solution provided a source document as an output in the desired PDF version and worked in sync with the “Data Entry Tool for ICSR” solution. AiRo is working on further enhancing the prototype to generate E2B compliant XML output. The chatbot eliminated any human error and reduced the requirement for training, which improved the overall efficiency of the AE case processing.

Voice-enabled Chatbot brings multiple benefits to the client’s Adverse Event Processing

The deployment of the chatbot by AiRo helped the client company streamline the AE case processing and reduce the requirement for training and manual labor. The solution provided real-time reporting, reduced compliance risk, and eliminated any human error, resulting in improved efficiency and accuracy. The life sciences company was able to maintain its cost base while processing a large volume of AE cases and ensuring compliance with regulatory requirements.

The deployment of the chatbot resulted in several benefits for the client company, including:

• Intelligent automation helped the company process 200,000 AE cases annually, which was previously a manual and time-consuming process.

• Real-time reporting was improved by 73%, which allowed the company to respond quickly to adverse events.

• Compliance risk was reduced by 25% due to the automated process, which eliminated any human error and the requirement for training.

• The source document was provided as an output in the desired PDF version, which allowed for easy and accurate record-keeping.